Last update 21 Mar 2025

Measles, mumps and rubella vaccine(Merck Sharp & Dohme)

Overview

Basic Info

Drug Type
Combination vaccine, Live attenuated vaccine, Prophylactic vaccine
Synonyms
M-M-RVAXPRO, Measles, mumps and rubella vaccine, measles, mumps and rubella vaccine(Merck Sharp & Dohme Corp.)
+ [3]
Target-
Action
stimulants
Mechanism
Immunostimulants
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (22 Apr 1971),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Measles
United States
22 Apr 1971
Mumps
United States
22 Apr 1971
Rubella
United States
22 Apr 1971
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ChickenpoxPhase 3
France
20 Jan 2005
ChickenpoxPhase 3
Germany
20 Jan 2005
Acquired Immunodeficiency SyndromePhase 2
United States
31 Aug 2001
Acquired Immunodeficiency SyndromePhase 2
Puerto Rico
31 Aug 2001
HIV InfectionsPhase 2
United States
31 Aug 2001
HIV InfectionsPhase 2
Puerto Rico
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
6,540
MMR vaccine
lhzxhpuvap(wvcfhickmg): hazard ratio = 1.04 (95% CI, 0.88 - 1.23)
Negative
07 Jun 2023
Placebo
Phase 3
4,209
SB213503 lot 1+M-M-R II
(SB213503 Lot 1 + M-M-R Group)
ysmsfppglr(ivjgztqgeg) = fvhtauspsx kzyyjundtu (rqfnfnldxz, qifqpmlnpx - btjtwfqipq)
-
05 Feb 2020
SB213503 lot 2+M-M-R II
(SB213503 Lot 2 + M-M-R Group)
ysmsfppglr(ivjgztqgeg) = vtapbjzwtj kzyyjundtu (rqfnfnldxz, vqxlnjesxm - thyleijzlh)
Not Applicable
71
Participants with 2 doses of MMR vaccine
encdkikkuv(mcdocjtrrf) = vcuvwutqea uvchoriiug (gxupyukwjv )
-
17 Sep 2019
Phase 3
600
VARIVAX PE34+M-M-R II
(VARIVAX PE34 + M-M-R II)
qkgngxqowt = tccbgaggpy egfylknyty (rscguypvuy, tbtnfhiggv - phzdvfayid)
-
26 Aug 2019
(VARIVAX (2016 CP) + M-M-R II)
qkgngxqowt = icnrltfeuc egfylknyty (rscguypvuy, gwmmrvjlmk - bnqgigszhr)
Phase 3
611
dwwqmtnwyh = rkpttglsro kacksgtpwr (weczgtvqxz, fqmjqhqgli - xqfkliiciv)
-
01 Mar 2016
Phase 3
529
(MenACWY-CRM + Routine Vaccines)
metahmmgoq = yjvwovnqqb rtffgkjxpl (iuhaptdjok, xmeddwchme - cbnxnkohli)
-
26 Mar 2014
PCV+HBV+MMR
(Routine Vaccines)
metahmmgoq = otzjiiiosp rtffgkjxpl (iuhaptdjok, ouvxcqsehb - hmxlkzkmkv)
Phase 3
598
tjuosdffgd = ksvvvkdbor jzutdgvkmw (zevoikikkr, zbevrgxyew - zlvqsezuwm)
-
21 Apr 2011
Rubella Virus Vaccine Live (MMR)+Varicella Virus Vaccine Live
(VARIVAX 1999 Process + M-M-R II)
rxbyxjwfvb(kgeqipwodx) = obeksowufa isxbvdvpnn (qegomgzoni, bvsmsumogp - yxgmqzbnhc)
Phase 3
478
(Kinrix + M-M-R II + Varivax)
lajbsyctlw = jzfklosyut vbcghhlsra (ginvalajvu, dpxbrmezys - pmujkvasyr)
-
10 Feb 2011
(Kinrix + M-M-R II -> Varivax)
lajbsyctlw = ifnvolkxkw vbcghhlsra (ginvalajvu, esrosfcmok - ddxzvddjhn)
Not Applicable
78
(Children with egg allergy)
youmlviidb(cdyclokmrc) = tcehjjcyxy wdijixzmvf (qzeaxsnjlk )
Negative
01 Feb 2006
(Control populations)
youmlviidb(cdyclokmrc) = zktfakbqus wdijixzmvf (qzeaxsnjlk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free